Lengo Therapeutics
About:
Lengo Therapeutics a biopharmaceutical company focused on the discovery and development of cancer treatments.
Website: https://www.lengotx.com/
Top Investors: Frazier Healthcare Partners
Description:
Lengo Therapeutics a biopharmaceutical company focused on the discovery and development of cancer treatments. Lengo works to identify several mutations in cancers that were not well addressed by existing therapeutics, helping medical practitioners and pharma companies to target driver mutations in oncology.
Total Funding Amount:
$15M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)lengotx.com
Founders:
Tracy Saxton
Number of Employees:
11-50
Last Funding Date:
2020-05-12
IPO Status:
Private
Industries:
© 2025 bioDAO.ai